OptimizeRx News

JMP Securities Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 11 02:31

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsSep 10 21:32

RBC Capital Maintains Outperform on OptimizeRx, Lowers Price Target to $14

BenzingaAug 16 23:27

OptimizeRx Analyst Ratings

BenzingaAug 16 23:25

RBC Capital Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $14

Futu NewsAug 16 19:34

OptimizeRx Price Target Cut to $11.00/Share From $15.00 by Barclays

Dow JonesAug 12 20:35

OptimizeRx Analyst Ratings

BenzingaAug 12 20:25

Barclays Sticks to Its Hold Rating for OptimizeRx (OPRX)

TipRanksAug 12 15:52

Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)

TipRanksAug 9 21:23

OptimizeRx Maintains Buy Rating: Robust Sales Pipeline and Improved Operational Efficiency Signal Strong Future Growth

TipRanksAug 9 12:28

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $17

Futu NewsAug 6 21:33

Lake Street Remains a Buy on OptimizeRx (OPRX)

TipRanksAug 6 21:10

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $16 Price Target

BenzingaJun 24 23:42

Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know

BenzingaJun 22 00:04

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $16 Price Target

BenzingaJun 21 23:04

OptimizeRx Analyst Ratings

BenzingaJun 21 23:03

OptimizeRx Analyst Ratings

BenzingaMay 15 19:55

Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)

TipRanksMay 15 19:02

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), PepGen Inc. (PEPG) and RegenXBio (RGNX)

TipRanksMay 15 18:35

Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)

TipRanksMay 15 17:35